美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SPDR S&P International Industria

34.71

0.0000

成交量：- -

成交額：- -

市值：2,082.60萬

市盈率：3.89

高：34.71

開：34.71

低：34.71

收：34.71

52周最高：34.71

52周最低：34.71

股本：60.00萬

流通股本：- -

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):8.93

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

益普生公布2025年上半年強勁業績並上調全年財務指引

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/IPN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"IPN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","market":"US","secType":"STK","nameCN":"SPDR S&P International Industria","latestPrice":34.71,"timestamp":1770748332549,"preClose":34.71,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":600000,"eps":8.9298,"marketStatus":"交易中","change":0,"latestTime":"02-10 13:32:12 EST","open":34.71,"high":34.71,"low":34.71,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.9298,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770757200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":34.71,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IPN\",,,,,undefined,":{"symbol":"IPN","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":600000,"dividePrice":0,"high":34.71,"amplitude":0,"preClose":34.71,"low":34.71,"week52Low":34.71,"pbRate":"--","week52High":34.71,"institutionHeld":0,"latestPrice":34.71,"eps":8.9298,"divideRate":0,"volume":0,"delay":0,"ttmEps":8.9298,"open":34.71,"prevYearClose":34.71,"prevWeekClose":34.71,"prevMonthClose":34.71,"prevQuarterClose":34.71,"fiveDayClose":34.71,"twentyDayClose":34.71,"sixtyDayClose":34.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IPN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-06-16","symbol":"IPN","amount":0.357922,"name":"SPDR S&P International Industria","recordDate":"2017-06-28","payableDate":"2017-06-20","currency":"USD","type":"dividend","dateTimestamp":1497585600000},{"market":"US","date":"2017-03-17","symbol":"IPN","amount":0.016732,"name":"SPDR S&P International Industria","recordDate":"2017-03-29","payableDate":"2017-03-21","currency":"USD","type":"dividend","dateTimestamp":1489723200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IPN\",market:\"US\",,,undefined,":[{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-29","value":0.016732,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-28","value":0.357922,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IPN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IPN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2557399040","title":"益普生公布2025年上半年強勁業績並上調全年財務指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2557399040","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557399040?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 12:32","pubTimestamp":1754368320,"startTime":"0","endTime":"0","summary":"在此基础上，我很高兴，益普生在销售和利润方面的全年指引做了上调。\" 2025年全年指引 基于上半年强劲的业绩表现，益普生上调了2025年全年财务指引：  以固定汇率计算，总销售额增长超过7.0%。2025年7月23日，欧盟委员会批准益普生将Cabometyx用于治疗既往接受治疗的晚期神经内分泌肿瘤患者。上述所有风险因素均可能影响益普生未来达成财务目标的能力，而这些目标是基于当前可获取信息并假设宏观经济环境相对稳定的前提下设定的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4744400_ZH44400_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["IPN","BK4007","IPSEY"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}]}}